New tariffs, primarily on medical technology products, are projected to add $400 million in costs this year, Chief Financial Officer Joseph Wolk said.

Ebert started her afternoon with a trip to Wasden Elementary School, where she visited several classrooms, including the only ...

J&J is projecting a $400m hit due to US tariffs in 2025, but reaffirmed its profit outlook while raising its sales forecast.

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

J&J’s comments and guidance update come as the company kicks off 2025’s first-quarter earnings round for large drugmakers.

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt primarily within the company’s medical technology unit, which makes a ...

Johnson & Johnson Chief Executive Joaquin Duato said on Tuesday that tariffs on pharmaceuticals can create supply chain ...

Ashton Jeanty is the top prospect in a loaded running back class but could fall down the order. Here's a scenario in which he goes later in Round 1.

Offseason moves have led GM Ryan Poles to feel like the Chicago Bears can lean toward the best player available in the 2025 NFL draft.

Are the Vikings ready to deal with the Bears being good again? The NFC North was loaded in 2024, but 2025 it could be even more of a log jam.

It's hard to differentiate between the many great RBs in the 2025 NFL draft class but YAC could help the Dallas Cowboys decide ...